2019 annual financial data
Fulcrum Therapeutics 2019 Operating margin
Fulcrum Therapeutics 2019 operating margin with verified reported values.
Direct answer
Operating margin was -11,228.93%.
Operating income was -84,217,000 USD and net income was -79,113,000 USD.
Operating cash flow was -39,483,000 USD.
Get free Fulcrum Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 750,000 USD
- Operating income
- -84,217,000 USD
- Net income
- -79,113,000 USD
- Operating cash flow
- -39,483,000 USD